This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, C. Search for Related Content PubMed PubMed Citation Articles by Jones, C.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 10 1995, 549-556, Vol 8, No. 4
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Cervical cancer: is herpes simplex virus type II a cofactor?

C Jones
Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln 68583, USA.

In many ways, cervical cancer behaves as a sexually transmitted disease. The major risk factors are multiple sexual partners and early onset of sexual activity. Although high-risk types of human papillomaviruses (HPV) play an important role in the development of nearly all cases of cervical cancer, other sexually transmitted infectious agents may be cofactors. Herpes simplex virus type 2 (HSV-2) is transmitted primarily by sexual contact and therefore has been implicated as a risk factor. Several independent studies suggest that HSV-2 infections correlate with a higher than normal incidence of cervical cancer. In contrast, other epidemiological studies have concluded that infection with HSV-2 is not a major risk factor. Two separate transforming domains have been identified within the HSV-2 genome, but continued viral gene expression apparently is not necessary for neoplastic transformation. HSV infections lead to unscheduled cellular DNA synthesis, chromosomal amplifications, and mutations. These observations suggest that HSV-2 is not a typical DNA tumor virus. It is hypothesized that persistent or abortive infections induce permanent genetic alterations that interfere with differentiation of cervical epithelium and subsequently induce abnormal proliferation. Thus, HSV-2 may be a cofactor in some but not all cases of cervical cancer.

This article has been cited by other articles:

• Fakhry, C., D'souza, G., Sugar, E., Weber, K., Goshu, E., Minkoff, H., Wright, R., Seaberg, E., Gillison, M. (2006). Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women. J. Clin. Microbiol. 44: 4479-4485 [Abstract] [Full Text]  
• Smith, J. S., Herrero, R., Bosetti, C., Munoz, N., Bosch, F. X., Eluf-Neto, J., Castellsague, X., Meijer, C. J. L. M., Van den Brule, A. J. C., Franceschi, S., Ashley, R. (2002). Herpes Simplex Virus-2 as a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer. JNCI J Natl Cancer Inst 94: 1604-1613 [Abstract] [Full Text]